beta-Agonists regulate Na,K-ATPase via novel MAPK/ERK and rapamycin-sensitive pathways

Citation
L. Pesce et al., beta-Agonists regulate Na,K-ATPase via novel MAPK/ERK and rapamycin-sensitive pathways, FEBS LETTER, 486(3), 2000, pp. 310-314
Citations number
41
Categorie Soggetti
Biochemistry & Biophysics
Journal title
FEBS LETTERS
ISSN journal
00145793 → ACNP
Volume
486
Issue
3
Year of publication
2000
Pages
310 - 314
Database
ISI
SICI code
0014-5793(200012)486:3<310:BRNVNM>2.0.ZU;2-Z
Abstract
We studied whether the beta -adrenergic agonist, isoproterenol (ISO), regul ates Na,K-ATPase in alveolar epithelial cells (AEC) via a mitogen-activated protein kinase (MAPK)/ extracellular signaling related kinase (ERK) depend ent pathway. ISO increased ERK activity in AEC by 10 min via a beta -adrene rgic receptor, protein kinase A (PKA)-dependent mechanism. Activation of th e MAPK pathway by ISO, resulted in increased Na,K-ATPase beta 1and alpha1 s ubunit protein abundance in whole cell lysates, which resulted in functiona l Na,K-ATPases at the basolateral membranes. ISO did not change the alpha1 or beta1 mRNA steady state levels, but rapamycin, the inhibitor of the mamm alian target of rapamycin, also blocked the ISO-mediated increase in Na,K-A TPase total protein abundance, suggesting a posttranscriptional regulation. We conclude that ISO, regulates the Na,K-ATPase in AEC via PKA, ERK and ra pamycin-sensitive mechanisms. (C) 2000 Federation of European Biochemical S ocieties. Published by Elsevier Science B.V. All rights reserved.